Mucormycosis, commonly referred to as black fungus, is a formidable fungal infection caused by mucormycetes molds. It predominantly afflicts individuals with compromised immune systems, including those with uncontrolled diabetes, transplant recipients, or cancer patients undergoing chemotherapy. Within the realm of ophthalmology, mucormycosis poses significant risks as it can invade the orbit, sinuses, and adjacent tissues. Symptoms range from severe headaches and facial swelling to potential vision loss, particularly when the infection reaches the orbital region or causes cavernous sinus thrombosis. Prompt diagnosis is critical for effective treatment, typically involving aggressive antifungal therapy like amphotericin B and surgical intervention to excise infected tissue. Prevention strategies emphasize managing underlying health conditions and maintaining rigorous hygiene practices, especially in healthcare settings. Heightened awareness among medical professionals is crucial for early detection and improved outcomes in cases of ocular mucormycosis.
Background: Mucormycosis is a deadly opportunistic fungal infection characterized by direct invasion with marked tissue necrosis of adjacent structures followed by rapid progression and angioinvasion…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Mucormycosis work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Mucormycosis research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Mucormycosis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Mucormycosis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Mucormycosis are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Mucormycosis track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
